Showing results (491-500 of 1,899) with videos related to
Sort By:
Pageof 190
Current Neuropharmacology|December 4, 2015
The Role of Topiramate in the Management of Cocaine Addiction: a Possible Therapeutic OptionAntonio Siniscalchi, Antonello Bonci, Nicola Biagio Mercuri, et al.Current Neuropharmacology|October 20, 2017
E-cigarettes: Impact of E-Liquid Components and Device Characteristics on Nicotine ExposureElise E DeVito, Suchitra Krishnan-SarinCurrent Neuropharmacology|February 24, 2016
Mitochondrial Biology and Neurological DiseasesSiddharth Arun, Lei Liu, Gizem DonmezCurrent Neuropharmacology|February 24, 2016
Kappa Opioids, Salvinorin A and Major Depressive DisorderGeorge T Taylor, Francesca ManzellaCurrent Neuropharmacology|January 18, 2017
The Amyloid Cascade Hypothesis in Alzheimer's Disease: It's Time to Change Our MindRoberta Ricciarelli, Ernesto FedeleCurrent Neuropharmacology|November 12, 2016
Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to PigsNadine Schaefer, Mattias Kettner, Matthias W Laschke, et al.Current Neuropharmacology|August 17, 2019
Targeting Serotonin1A Receptors for Treating Chronic Pain and DepressionDarakhshan Jabeen HaleemCurrent Neuropharmacology|October 2, 2019
Modeling Neuronal Diseases in Zebrafish in the Era of CRISPRAngeles Edith Espino-Saldaña, Roberto Rodríguez-Ortiz, Elizabeth Pereida-Jaramillo, et al.Current Neuropharmacology|October 2, 2019
The Cold Case of Metabotropic Glutamate Receptor 6: Unjust Detention in the Retina?E Palazzo, S Boccella, I Marabese, et al.Current Neuropharmacology|February 16, 2021
Study of Nutraceuticals and Phytochemicals for the Management of Alzheimer's Disease: A ReviewSyed Sayeed Ahmad, Mohammad Khalid, Mohammad A Kamal, et al.Pageof 190